India ready to supply Hydroxychloroquine, the Donald Trump wants

India will partially lift the ban on exports of the anti-malaria drug Hydrochloroquine seen as crucial for protection of healthcare workers treating Covid-19 patients. The decision comes in the wake of US President Donald Trump's threat of retaliation in the event India declines Trump's request for the supply of the drug. The US President had called up Prime Minister Narendra Modi on Sunday and urged him to release the anti-malaria drug that he sees as a Covid game changer. India has eased restrictions on exports of the anti-malaria drug Hydroxycholoroquine and pain reliever paracetamol on case-by-case basis. According to MEA, India will licence the two drugs in appropriate quantities to all neighbouring countries and also the ones that are worst-affected by the new coronavirus pandemic.